Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,440 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04557449RecruitingPhase 1/Phase 2
Study of an experimental drug for advanced solid tumors
This trial tests a new drug (PF-07220060) for people with advanced solid tumors, including certain types of breast, lung, prostate, and colorectal cancers. The drug may help slow tumor growth, and researchers are checking its safety and effectiveness.
Los Angeles, CaliforniaAges 18 years+ - NCT07886827Recruiting
Electrical stimulation and exercise for shoulder pain in older adults
This trial tests a treatment that uses mild electrical stimulation along with exercise to reduce shoulder pain and improve movement in older adults. It may help if you have persistent shoulder pain that gets worse when you lift your arm.
Austin, TexasAges 60 years+ - NCT07876076RecruitingPhase 1
Testing a new medicine for safety in healthy adults
This trial tests a new medicine called ADX-001 in healthy adults to see if it is safe, how the body handles it, and whether it triggers an immune response. It is an early-stage study, so it will help determine if the drug is safe enough for further testing in people with certain conditions.
Adelaide, South AustraliaAges 18–55 - NCT07120503RecruitingPhase 2
Study of WIN378 for moderate or severe asthma
This study tests an investigational medicine called WIN378, given as an injection, to see if it is safe and helps control moderate or severe asthma. It may be an option for people whose asthma is not well controlled with their current inhalers.
Los Angeles, CaliforniaAges 18–75 - NCT06043674RecruitingPhase 2
Study of glofitamab alone or with other drugs for Richter's transformation
This study tests a new drug called glofitamab, alone or with other targeted drugs, for people with Richter's transformation (when CLL or SLL turns into a more aggressive lymphoma). It aims to see if these combinations can shrink tumors and improve outcomes.
Atlanta, GeorgiaAges 18 years+ - NCT07264270RecruitingPhase 1
New drug for chronic sciatica pain
This early-stage study tests a new drug called C-1101 to see if it is safe for people with chronic sciatica (pain that travels down the leg from the lower back). It aims to help patients who haven't found relief with standard treatments.
Fernandina Beach, FloridaAges 18–70 - NCT05168566RecruitingPhase 2
Sutetinib for advanced lung cancer with uncommon EGFR mutations
This trial tests a new pill called Sutetinib for people with advanced non-small cell lung cancer that has certain uncommon EGFR mutations. It aims to see if the drug can shrink tumors and help patients live longer.
Glendale, CaliforniaAges 18 years+ - NCT05911217RecruitingPhase 1
Study of CT041 after chemotherapy for pancreatic cancer
This trial tests a new treatment called CT041, which uses your own immune cells to target a protein on cancer cells, after standard chemotherapy and surgery. It aims to see if it can prevent the cancer from coming back.
Beijing, Beijing MunicipalityAges 18–79 - NCT07886099Recruiting
Breathing exercises to help young people quit vaping
This study tests whether special breathing exercises can help young people (ages 15-25) stop using e-cigarettes (vaping). If you vape regularly and are not very active, you might be able to join.
Bangkok, BangkokAges 15–25 - NCT06971731RecruitingPhase 3
Study of a new pill for phenylketonuria
This study tests a new medicine, JNT-517, taken by mouth to help lower phenylalanine levels in people with PKU. It may be an option for those who need better control of their condition.
Los Angeles, CaliforniaAges 4 years+ - NCT06989840RecruitingPhase 1
Safety study of TVB-3567 in healthy adults with or without acne
This study tests a new medicine called TVB-3567 to see if it is safe and well-tolerated. It will be given to healthy people, and also to people with moderate to severe acne, to understand how the body processes it.
Tempe, ArizonaAges 18–55 - NCT06451952Recruiting
Virtual darkness therapy for agitation in dementia
This trial tests whether spending time in a specially designed virtual reality 'darkness' environment can help calm agitation in people with dementia. If you or a loved one often feels restless, anxious, or agitated, this therapy might offer a drug-free way to feel more settled.
Askøy, ErdalAges 50 years+ - NCT07623057RecruitingPhase 1
Safety Study of FB102 in Healthy Adults
This early-stage study tests whether a new drug called FB102 is safe in people without serious health conditions. Researchers will monitor volunteers closely to understand how the body handles the drug.
Eastwood, QueenslandAges 18–60 - NCT07630974RecruitingPhase 1/Phase 2
New Cancer Drug for Children With Hard-to-Treat Solid Tumors
This trial tests a new drug called ifinatamab deruxtecan in children whose solid tumors (cancers that form lumps, excluding brain tumors) have come back or stopped responding to previous treatments. The drug is designed to target and kill cancer cells while potentially causing fewer side effects than standard chemotherapy.
Los Angeles, CaliforniaAges 1 month–17 years - NCT07296315RecruitingPhase 2
Testing a new treatment for mild-to-moderate ulcerative colitis
This study tests an investigational drug for people with active mild-to-moderate ulcerative colitis. It aims to see if the drug can improve symptoms without needing advanced treatments like biologics.
Miami, FloridaAges 16 years+ - NCT07489495RecruitingPhase 3
Belzutifan and zanzalintinib for advanced kidney cancer
This study tests two new drugs, belzutifan and zanzalintinib, for people with advanced kidney cancer that has not responded well to other treatments. The goal is to see if the combination slows down cancer growth.
Marietta, GeorgiaAges 18 years+ - NCT06379789RecruitingPhase 1/Phase 2
Gene therapy for severe hemophilia B
This trial tests a new gene therapy (REGV131-LNP1265) that aims to let your body produce its own factor IX, reducing or stopping the need for regular infusions. It is for children and adults with severe hemophilia B who are already using factor IX replacement therapy.
Phoenix, ArizonaAges 2 years+ - NCT06686394RecruitingPhase 1/Phase 2
Patritumab deruxtecan combinations for advanced HER2-positive breast cancer
This trial tests a new drug, patritumab deruxtecan, combined with other anti-cancer drugs for people with HER2-positive breast cancer that has spread or cannot be removed by surgery. It aims to see if these combinations can shrink tumors or slow cancer growth.
Aurora, ColoradoAges 18 years+ - NCT05099172RecruitingPhase 1/Phase 2
Targeted therapy for advanced lung cancer with EGFR or HER2 changes
This trial tests a new targeted drug for people with advanced non-small cell lung cancer that has specific genetic changes (EGFR or HER2). The drug may slow cancer growth and help you live longer.
Gilbert, ArizonaAges 18 years+ - NCT06555029Recruiting
Oral health help for older adults on Medicaid
This trial is testing an oral health program offered during routine primary care visits for older adults (55+) on Medicaid. It aims to see if adding dental care support to regular check-ups can improve health.
Cleveland, OhioAges 55 years+ - NCT07735637RecruitingPhase 3
Comparing a new drug to stem cell transplant for multiple myeloma
This study compares a new investigational drug (AZD0120) with a standard stem cell transplant for people with newly diagnosed multiple myeloma who have already completed initial treatment. The goal is to see if the new drug works as well as or better than the transplant in keeping the cancer from coming back.
Gilbert, ArizonaAges 18–130 - NCT04606446RecruitingPhase 2
Study drug for ER-positive, HER2-negative cancers after treatment
This Phase 2 study tests a new Pfizer medicine (PF-07248144) for certain advanced or metastatic breast, prostate, or lung cancers that have not responded to standard treatment or no standard options exist. You may qualify if you have a specific tumor type and a limited number of prior cancer treatments, and if your body functions (blood, liver, kidneys) and heart rhythm meet safety limits.
Scottsdale, ArizonaAges 18 years+ - NCT07211958RecruitingPhase 3
Revumenib plus chemo for newly diagnosed AML with NPM1 mutation
This trial tests a new drug, revumenib, combined with strong chemotherapy for people with a specific type of AML (NPM1 mutation). The goal is to see if adding revumenib helps treat the leukemia better than chemo alone.
Goodyear, ArizonaAges 12 years+ - NCT07885150Enrolling by invitation
Choosing the best measures for AI image tools
This study asks patients, doctors, and others what outcomes matter most when testing AI tools that help read medical images. Your views could help shape future research so these tools are judged on what's truly important.
OxfordAges 18 years+
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,440 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.